Companies / Vertex Pharmaceuticals Inc / Ma / Activity
Activity — Vertex Pharmaceuticals Inc / Ma
56 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $9.21M | -20K -19.32% | 82,124 0.03% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $7.72M | -16K -12.81% | 105,998 0.04% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $5.51M | -12K -15.64% | 63,171 0.02% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $4.80M | -10K -9.16% | 101,786 0.04% of shares | medium |
| Jan 6, 2026 | Wagner Charles F Jr Executive | Sell | Common Stock | $4.39M | -10K -20.17% | 37,725 0.01% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $3.40M | -7K -8.82% | 74,883 0.03% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $2.97M | -6K -5.66% | 100,003 0.04% of shares | medium |
| Jan 7, 2026 | Tatsis Ourania Executive | Sell | Common Stock | $2.14M | -5K -9.62% | 42,293 0.02% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $2.00M | -4K -6.71% | 58,934 0.02% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.73M | -3K -2.80% | 121,578 0.05% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.60M | -3K -2.43% | 131,730 0.05% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.34M | -3K -2.08% | 128,545 0.05% of shares | medium |
| Mar 11, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.31M | -3K -17.41% | 12,489 <0.01% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $1.27M | -3K -2.34% | 113,897 0.04% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.24M | -3K -1.98% | 125,076 0.05% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $1.22M | -3K -1.83% | 135,008 0.05% of shares | medium |
| Feb 25, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.22M | -3K -11.13% | 19,969 <0.01% of shares | medium |
| Feb 17, 2026 | Biller Jonathan Executive | Sell | Common Stock | $1.21M | -2K -12.72% | 16,992 <0.01% of shares | medium |
| Feb 17, 2026 | Bunnage Mark E. Executive | Sell | Common Stock | $1.19M | -2K -20.13% | 9,668 <0.01% of shares | medium |
| Feb 25, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.18M | -2K -12.07% | 17,559 <0.01% of shares | medium |
| Mar 4, 2026 | McKechnie Duncan Executive | Sell | Common Stock | $1.16M | -2K -13.88% | 15,122 <0.01% of shares | medium |
| Mar 13, 2026 | Bozic Carmen Executive | Sell | Common Stock | $1.12M | -2K -6.17% | 35,405 0.01% of shares | medium |
| Feb 27, 2026 | Bozic Carmen Executive | Sell | Common Stock | $1.12M | -2K -5.81% | 37,734 0.01% of shares | medium |
| Mar 27, 2026 | Bozic Carmen Executive | Sell | Common Stock | $1.05M | -2K -6.58% | 33,076 0.01% of shares | medium |
| Feb 17, 2026 | Atkinson Edward Morrow III Executive | Sell | Common Stock | $994.1K | -2K -8.62% | 21,544 <0.01% of shares | medium |
| Feb 11, 2026 | Bunnage Mark E. Executive | Sell | Common Stock | $930.5K | -2K -13.53% | 12,914 <0.01% of shares | medium |
| Feb 25, 2026 | Sachdev Amit Executive | Sell | Common Stock | $897.8K | -2K -3.22% | 55,570 0.02% of shares | medium |
| Feb 11, 2026 | Biller Jonathan Executive | Sell | Common Stock | $886.3K | -2K -8.46% | 20,819 <0.01% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $860.8K | -2K -1.62% | 112,049 0.04% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $857.2K | -2K -1.72% | 98,278 0.04% of shares | medium |
| Feb 11, 2026 | Atkinson Edward Morrow III Executive | Sell | Common Stock | $806.2K | -2K -7.36% | 22,046 <0.01% of shares | medium |
| Feb 17, 2026 | Ambrose Kristen Executive | Sell | Common Stock | $762.1K | -2K -15.66% | 8,388 <0.01% of shares | medium |
| Feb 13, 2026 | Tatsis Ourania Executive | Sell | Common Stock | $750.0K | -2K -3.15% | 46,132 0.02% of shares | medium |
| Feb 11, 2026 | Ambrose Kristen Executive | Sell | Common Stock | $633.6K | -1K -11.96% | 10,127 <0.01% of shares | medium |
| Feb 18, 2026 | Biller Jonathan Executive | Sell | Common Stock | $589.3K | -1K -7.32% | 15,748 <0.01% of shares | medium |
| Feb 18, 2026 | Bunnage Mark E. Executive | Sell | Common Stock | $559.9K | -1K -12.23% | 8,486 <0.01% of shares | medium |
| Feb 13, 2026 | Biller Jonathan Executive | Sell | Common Stock | $493.0K | -988 -5.54% | 16,838 <0.01% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $466.2K | -949 -0.74% | 127,596 0.05% of shares | medium |
| Feb 25, 2026 | Biller Jonathan Executive | Sell | Common Stock | $459.6K | -945 -6.47% | 13,659 <0.01% of shares | medium |
| Mar 2, 2026 | Liu Joy Executive | Sell | Common Stock | $442.4K | -892 -3.76% | 22,811 <0.01% of shares | medium |
| Feb 19, 2026 | Sachdev Amit Executive | Sell | Common Stock | $426.8K | -920 -0.78% | 116,627 0.05% of shares | medium |
| Feb 18, 2026 | Atkinson Edward Morrow III Executive | Sell | Common Stock | $387.0K | -817 -3.79% | 20,727 <0.01% of shares | medium |
| Feb 25, 2026 | Atkinson Edward Morrow III Executive | Sell | Common Stock | $324.9K | -668 -3.50% | 18,432 <0.01% of shares | medium |
| Feb 18, 2026 | Ambrose Kristen Executive | Sell | Common Stock | $302.2K | -638 -7.61% | 7,750 <0.01% of shares | medium |
| Feb 25, 2026 | Bunnage Mark E. Executive | Sell | Common Stock | $301.5K | -620 -7.84% | 7,284 <0.01% of shares | medium |
| Feb 17, 2026 | Tatsis Ourania Executive | Sell | Common Stock | $298.1K | -609 -1.23% | 49,018 0.02% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $225.1K | -460 -0.35% | 131,270 0.05% of shares | medium |
| Feb 11, 2026 | Tatsis Ourania Executive | Sell | Common Stock | $214.6K | -466 -0.90% | 51,436 0.02% of shares | medium |
| Feb 27, 2026 | Kewalramani Reshma CEO | Sell | Common Stock | $191.9K | -400 -0.29% | 137,878 0.05% of shares | medium |
| Feb 18, 2026 | Tatsis Ourania Executive | Sell | Common Stock | $174.3K | -368 -0.75% | 48,650 0.02% of shares | medium |